One of the most critical drivers of success in any company is its team—especially for startups and SMEs. For founders, the challenge is sourcing the right talent to bring their vision to life. For investors, the question is whether the company has the right people, at the right time, to execute effectively. Looking at our own Edmonton ecosystem, what challenges and unexpected lessons have we encountered?

Speaker

Desmond Pink is the co-founder and Chief Science Officer of Nanostics Inc., where he co-leads the development of novel diagnostic technologies to improve cancer screening and patient outcomes.

About Nanostics

Nanostics Inc. is a private precision health company based in Edmonton, Alberta. It develops and commercializes noninvasive diagnostic tests powered by its proprietary ClarityDX® platform, which uses advanced machine learning techniques to integrate disease biomarkers and clinical features to provide accurate disease risk assessments. Its lead product, ClarityDX Prostate®, helps physicians to more effectively identify patients at risk of clinically significant prostate cancer—improving screening accuracy and reducing unnecessary biopsies.